{"id":41310,"date":"2020-11-02T22:59:19","date_gmt":"2020-11-02T14:59:19","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=127773"},"modified":"2020-11-02T22:59:19","modified_gmt":"2020-11-02T14:59:19","slug":"taiwan-company-to-enroll-vietnamese-nationals-in-covid-19-vaccine-trial","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2020\/11\/02\/taiwan-company-to-enroll-vietnamese-nationals-in-covid-19-vaccine-trial\/","title":{"rendered":"Taiwan company to enroll Vietnamese nationals in COVID-19 vaccine trial"},"content":{"rendered":"<p>Taipei, Nov. 2 (CNA) Taiwan&#8217;s Medigen Vaccine Biologics Corp. (MVC) has signed an agreement with Vietnam to include Vietnamese nationals in a clinical trial of the company&#8217;s COVID-19 vaccine, MVC announced Monday.<\/p>\n<p>The &#8220;MVC-COV1901 vaccine injection,&#8221; jointly developed by MVC and the U.S.&#8230;<\/p>\n<p>This news comes via <a href=\"https:\/\/www.chinapulse.com\/\"  title=\"Best source for Chinese news in English\">ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Taipei, Nov. 2 (CNA) Taiwan's Medigen Vaccine Biologics Corp. (MVC) has signed an agreement with Vietnam to include Vietnamese nationals in a clinical trial of the company's COVID-19 vaccine, MVC announced Monday.<br \/>\nThe \"MVC-COV1901 vac&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[213,1607,288,194,64],"tags":[10324,8809,2492,7035,3904],"class_list":["post-41310","post","type-post","status-publish","format-standard","hentry","category-china-news","category-manufacturing","category-medicine","category-news-chinese-law","category-taiwan","tag-covid-19","tag-manufacturer","tag-taipei","tag-vaccine","tag-vietnam"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/41310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=41310"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/41310\/revisions"}],"predecessor-version":[{"id":41311,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/41310\/revisions\/41311"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=41310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=41310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=41310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}